ONCOLOGY
February 11, 2022
Breast Cancer and Cardiovascular Disease Risk
Although agents used to treat this form of cancer have greatly reduced patient morbidity and mortality, these drugs often carry a risk of significant adverse cardiac effects.
January 14, 2022
Pharmacist Involvement in Antibody-Drug Conjugate Therapy
December 17, 2021
Incidence, Survival, and Mortality Rates for Colorectal Cancer
October 19, 2021
First CDK4/6 Inhibitor for HR+ HER2Ð High-Risk BC
October 19, 2021
Research Reveals Two Forms of Metastatic Prostate Cancer
October 15, 2021
Review of Selected NMEs 2021
October 5, 2021
Take Quiz: Ovarian Cancer
September 21, 2021
PARP Inhibitor Maintenance Therapy Expanding in Recurrent Ovarian Cancer
September 21, 2021
Research Reveals How PARP Inhibitors Work
September 1, 2021
Some BP Drugs Show Association With Colorectal Cancer Survival
Related CE
$6.97 Per CE Exam or $59 for 12 Lessons
Copyright © 2000 - 2022 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.